Financial Architects, Inc - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 101 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
Financial Architects, Inc ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2020$6,000
+50.0%
150
-85.0%
0.00%0.0%
Q4 2017$4,0000.0%1,0000.0%0.00%0.0%
Q3 2017$4,000
+100.0%
1,0000.0%0.00%
Q2 2017$2,0000.0%1,0000.0%0.00%
Q1 2017$2,0000.0%1,0000.0%0.00%
Q4 2016$2,000
-71.4%
1,0000.0%0.00%
-100.0%
Q3 2016$7,000
-66.7%
1,000
-75.0%
0.00%
-66.7%
Q2 2016$21,0004,0000.01%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q3 2016
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders